Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

ALEXANDRIA — The Alzheimer’s Association is inviting community members to come together to fight for a different future at ...

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s ...

Explaining the Alzheimer’s Journey will be held on October 10 at the University of Findlay. The event will focus on the ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the ...

A new analysis of classical medical texts suggests dementia was extremely rare in ancient Greece and Rome 2,000 to 2,500 ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

The MIND diet, which stands for Mediterranean-DASH Diet Intervention for Neurodegenerative Delay, is a hybrid of the ...

The Dutch company has created a device for the early detection of Alzheimer’s disease, and it is on its way to developing ...

(RTTNews) - Eli Lilly and Company (LLY) Tuesday said its Kisunla for the treatment of adults with early symptomatic Alzheimer's disease has been approved by the Ministry of Health, Labour and Welfare ...

Eli Lilly on Tuesday said Japan's Ministry of Health, Labour and Welfare Japan approved Kisunla for adults with early symptomatic Alzheimer's, including those with mild cognitive impairment as well as ...

Eli Lilly’s (NYSE:LLY) treatment for early Alzheimer's disease has been approved for use in Japan. Kisunla (donanemab-azbt), which is given via infusion once a month, is indicated for treatment of ...